Nieuwegein

• PET/CT imaging with FAPI as a biomarker for the distinction between predominant active fibrotic and inflammatory phenotypes in patients with … Recruiting
  2023-503686-26-02 9 2025-01-24 Progressive Pulmonary Fibrosis (PPF)
• Assessment of the value of FAPI and FDG-PET-CT in the diagnosis of acute phase Peyronie’s Disease Recruiting
  2024-518838-82-00 6 2024-12-13 Peyronie's Disease
• Ulipristal versus surgery for symptomatic uterine fibroids Recruiting
  2024-512602-26-00 6 2024-12-02 Uterine fibroids
• Iberdomide combined with low-dose cyclophosphamide and dexamethasone: ICON study Recruiting
  2023-508902-66-00 4 2024-11-28 relapsed / refractory multiple myeloma
• The PREDMETH trial: Effectiveness of methotrexate versus prednisone as first-line therapy for pulmonary sarcoidosis – A randomized controlle … Recruiting
  2024-514055-15-00 6 2024-11-19 Pulmonary sarcoidosis
• The dosage of antithrombotics adjusted to body weight Recruiting
  2024-518890-33-00 6 2024-11-12 Chronic coronary syndrome
• DISTINCT: inDividual, targeted thrombosIS prophylaxis versus the standard ‘one size fits all’ approach in patients undergoing Total hIp or t … Recruiting
  2023-510186-98-00 6 2024-10-23 Venous thromboembolism
• Local Levobupivacaine for pain reflief after esophageal ESD Recruiting
  2024-510912-66-00 6 2024-10-22 Visible esophageal lesions ((pre)cancerous)
• Remimazolam versus Midazolam for sedation during upper GI endoscopy: a randomized controlled trial Recruiting
  2024-516432-94-00 6 2024-10-21 N/A
• A study to test whether vicadrostat (BI 690517) in combination with empagliflozin helps people with heart failure. Recruiting
  2023-509706-30-00 5 2024-10-18 Heart failure (HF)
• POPular GUILTY PILOT: Genotype-guided Clopidogrel monotherapy Recruiting
  2024-518464-12-00 6 2024-10-15 Non-ST-segment Elevation Acute Coronary Syndrome
• DOSAgE study: A multicenter randomized phase III trial of DOSe-reduced Chemotherapy for Advanced Colorectal Cancer in Older patients Recruiting
  2023-506115-17-00 5 2024-10-14 Metastatic Colorectal Cancer
• Clinical trial comparing MK-2870 given with pembrolizumab to pembrolizumab alone in participants who have had surgery for NSCLC Recruiting
  2023-508012-35-00 5 2024-10-02 Newly diagnosed NSCLC with resectable clinical Stage II, IIIA or IIIB
• PREOPANC-5 Recruiting
  2023-508707-20-00 9 2024-09-19 Borderline resectable pancreatic cancer (BRPC)
• A follow-up study to test long-term treatment with BI 1015550 in people with pulmonary fibrosis who took part in a previous study with BI 10 … Recruiting
  2023-507353-15-00 5 2024-09-10 idiopathic pulmonary fibrosis (IPF)
• A study to assess the efficacy and safety of OATD-01 for the treatment of active pulmonary sarcoidosis. Recruiting
  2023-506642-23-01 4 2024-08-28 Active Pulmonary Sarcoidosis
• Intravenous iron to treat postoperative anaemia in older cardiac surgery patients: a randomized controlled trial (AGE ANAEMIA study) Recruiting
  2024-515920-35-01 6 2024-08-22 iron deficiency anaemia
• HOVON 170 DLBCL: ANTICIPATE: Prevention of ANThracycline-Induced Cardiac dysfunction by dexrazoxane In PATients with diffusE large B-cell ly … Recruiting
  2023-505377-32-00 5 2024-08-15 Diffuse large B-cell lymphoma (DLBCL)
• CLEAR-PATH trial Recruiting
  2024-513363-15-01 11 2024-07-22 (Chronic) Peripheral (occlusive) arterial disease (PAD)
• A randomized double-blind, placebo-controlled, multicenter trial assessing the impact of lipoprotein(a) lowering with pelacarsen (TQJ230) on … Recruiting
  2022-502135-19-00 4 2024-07-18 Calcific Aortic Valve Stenosis
• Pro-RAPID Recruiting
  2023-507352-72-00 6 2024-05-24 Crohn's Disease
• FeAsiBility of a treatment free interval in newly diagnosed mUltiple myeLOma patients treated with DaratumUmab-Lenalidomide-DexamethaSone – … Recruiting
  2023-508586-33-00 5 2024-05-14 multiple myeloma
• Metamizole as pain treatment in patients with chronic pancreatitis, a multicenter, randomized, double-blind, placebo-controlled, superiority … Recruiting
  2023-504143-14-00 6 2024-05-02 Chronic pancreatitis
• Clinical Outcome and Cost-effectiveness of Reduced Noradrenaline by Using a Lower Blood Pressure Target in Patients with Cardiogenic Shock f … Recruiting
  2024-510892-40-00 6 2024-02-29 Acute myocardial infarction complicated by cardiogenic shock

Showing 49–72 of 150 trials